NL8102362A - Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. - Google Patents

Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number
NL8102362A
NL8102362A NL8102362A NL8102362A NL8102362A NL 8102362 A NL8102362 A NL 8102362A NL 8102362 A NL8102362 A NL 8102362A NL 8102362 A NL8102362 A NL 8102362A NL 8102362 A NL8102362 A NL 8102362A
Authority
NL
Netherlands
Prior art keywords
lactic acid
amsa
preparation
water
solution
Prior art date
Application number
NL8102362A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8102362A publication Critical patent/NL8102362A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8102362A 1980-05-16 1981-05-13 Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. NL8102362A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14705680 1980-05-16
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (1)

Publication Number Publication Date
NL8102362A true NL8102362A (nl) 1981-12-16

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8102362A NL8102362A (nl) 1980-05-16 1981-05-13 Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.

Country Status (21)

Country Link
US (1) US4360523A (fr)
JP (1) JPS579716A (fr)
AT (1) AT374682B (fr)
AU (1) AU543726B2 (fr)
BE (1) BE888832A (fr)
CA (1) CA1160571A (fr)
CH (1) CH647677A5 (fr)
DE (1) DE3119510A1 (fr)
DK (1) DK159376C (fr)
FI (1) FI70793C (fr)
FR (1) FR2482458A1 (fr)
GB (1) GB2076288B (fr)
GR (1) GR75658B (fr)
IE (1) IE51285B1 (fr)
IT (1) IT1170970B (fr)
LU (1) LU83363A1 (fr)
NL (1) NL8102362A (fr)
NZ (1) NZ196985A (fr)
SE (1) SE460457B (fr)
YU (1) YU44831B (fr)
ZA (1) ZA813188B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
DE3819842C1 (fr) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (fr) * 1994-03-22 1995-09-23 Prakash Parab Methode permettant d'accroitre le rythme de penetration dans la peau de l'acide lactique par l'utilisation de l'enantiomere l
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006002887A1 (fr) * 2004-06-29 2006-01-12 Baxter International Inc. Solution a boire aqueuse d'indibuline (d-24851) et d'un acide organique
MX2007005434A (es) * 2004-11-08 2007-07-10 Baxter Int Composiciones de nanoparticulado de inhibidor de tubulina.
EP2091532A1 (fr) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Utilisation de dérivés d'acide indolyl-3-glyoxylique comprenant de l'indibuline, seuls ou combinés à d'autres agents, pour traiter le cancer
US10434077B2 (en) 2014-03-31 2019-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
JPH0136445B2 (fr) 1989-07-31
AU7029181A (en) 1981-11-19
JPS579716A (en) 1982-01-19
DE3119510A1 (de) 1982-02-25
GB2076288A (en) 1981-12-02
YU112381A (en) 1985-03-20
FI811474L (fi) 1981-11-17
GB2076288B (en) 1983-12-14
IT1170970B (it) 1987-06-03
IE811092L (en) 1981-11-16
YU44831B (en) 1991-04-30
CA1160571A (fr) 1984-01-17
CH647677A5 (de) 1985-02-15
AT374682B (de) 1984-05-25
NZ196985A (en) 1983-06-17
DK216681A (da) 1981-11-17
AU543726B2 (en) 1985-05-02
BE888832A (fr) 1981-11-16
FR2482458B1 (fr) 1984-12-14
IT8148467A0 (it) 1981-05-14
LU83363A1 (fr) 1982-01-20
DK159376C (da) 1991-03-25
FI70793B (fi) 1986-07-18
ZA813188B (en) 1982-05-26
GR75658B (fr) 1984-08-02
SE460457B (sv) 1989-10-16
ATA221181A (de) 1983-10-15
IE51285B1 (en) 1986-11-26
US4360523A (en) 1982-11-23
SE8103071L (sv) 1981-11-17
FR2482458A1 (fr) 1981-11-20
DK159376B (da) 1990-10-08
DE3119510C2 (fr) 1991-03-07
FI70793C (fi) 1986-10-27

Similar Documents

Publication Publication Date Title
CN102018714B (zh) 制剂
US6673805B2 (en) Platinum derivative pharmaceutical formulations
NL8102362A (nl) Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.
AU599034B2 (en) Furosemide salts
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
EP0261426B1 (fr) Compositions pharmaceutiques lyophilisées d'acides phénylquinoléinecarboxyliques
US4425348A (en) Antitumor compositions
JP2000509013A (ja) ウルソデオキシコール酸またはタウロウルソデオキシコール酸、強塩基、およびトロメタモールを含む注射可能な薬学的組成物
JPH0343251B2 (fr)
US6818662B2 (en) Pharmaceutical composition
US4322424A (en) Crystalline glucoconate salt of m-AMSA and compositions containing same
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
NL8006440A (nl) Verbindingen en preparaten met anti-tumorwerking; werkwijze voor het bereiden daarvan.
CA1159368A (fr) Compose antitumoral
JP2022519343A (ja) ベンゾアゼピン化合物含有医薬組成物

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed